Press releases
- Spyre Therapeutics to Participate in the Jefferies Global Healthcare Conference
- Spyre Therapeutics Appoints Accomplished Biopharma Leader Dr. Sandra Milligan to its Board of Directors
- Spyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
- Spyre Therapeutics Announces Grants of Inducement Awards
- Spyre Therapeutics Announces $180 Million Private Placement
More ▼
Key statistics
On Friday, Spyre Therapeutics Inc (3920:DEU) closed at 32.45, 12.09% above the 52 week low of 28.95 set on May 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 30.90 |
---|---|
High | 32.45 |
Low | 30.90 |
Bid | 31.75 |
Offer | 32.75 |
Previous close | 31.25 |
Average volume | 0.00 |
---|---|
Shares outstanding | 50.78m |
Free float | 35.73m |
P/E (TTM) | -- |
Market cap | 1.77bn USD |
EPS (TTM) | -71.35 USD |
Data delayed at least 15 minutes, as of May 31 2024.
More ▼